Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-24 @ 2:31 PM
NCT ID:
NCT07138859
Eligibility Criteria:
Inclusion Criteria:
1. 18 years old\<age\<80 years old, regardless of gender;
2. The primary lesion of the colon was diagnosed as colon adenocarcinoma (well differentiated adenocarcinoma, moderately differentiated adenocarcinoma, poorly differentiated adenocarcinoma, mucinous adenocarcinoma) through endoscopic biopsy tissue pathology;
3. The preoperative clinical staging was cStage I-III (cT1-4a, N0/+, M0) (according to UICC/AJCC-8thTNM tumor staging);
4. The primary lesions of the colon are located in the cecum, ascending colon, hepatic flexure of the colon, and right half of the transverse colon. It is expected that right-sided colectomy and D3 lymph node dissection can achieve R0 surgical results (excluding multiple primary cancers);
5. Preoperative examination showed no distant metastasis, and the tumor did not directly invade adjacent organs;
6. Preoperative ECOG physical status score ≤ 2;
7. Preoperative ASA scores I-III;
8. Patient informed consent.
Exclusion Criteria:
1. History of colon surgery (excluding ESD/EMR for colon cancer);
2. History of major abdominal surgery (excluding laparoscopic cholecystectomy and appendectomy);
3. Preoperative body temperature ≥ 38 ℃ or complicated with infectious diseases requiring systematic treatment;
4. Pregnant or lactating women;
5. Suffering from severe mental illness;
6. Multiple primary cancers;
7. History of other malignant diseases within 5 years;
8. Any neoadjuvant therapy such as chemotherapy, radiotherapy, targeted therapy, immunotherapy, etc. has been implemented;
9. History of unstable angina or myocardial infarction within 6 months;
10. Heart, lung, liver, kidney dysfunction or history of cerebral infarction;
11. Simultaneous surgical treatment is required for other diseases;
12. Colorectal cancer complications (bleeding, perforation, obstruction) require emergency surgery.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07138859
Study Brief:
Protocol Section:
NCT07138859